Commentaries
Don't stop antithrombotics for cutaneous surgery: just do it now!
First published: 16 March 2015
No abstract is available for this article.
References
- 1Palamaras I, Semkova K. Perioperative management of and recommendations for antithrombotic medications in dermatological surgery. Br J Dermatol 2015; 172: 597–605.
- 2Callahan S, Goldsberry A, Kim G, Yoo S. The management of antithrombotic medication in skin surgery. Dermatol Surg 2012; 38: 1417–26.
- 3Douketis JD, Spyropoulos AC, Spencer FA et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl. 2): e326S–50S.
- 4Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 2003; 48: 233–7.
- 5O'Neill JL, Taheri A, Solomon JA, Pearce DJ. Postoperative hemorrhage risk after outpatient dermatologic surgery procedures. Dermatol Surg 2014; 40: 74–6.
- 6Amici JM, Rogues AM, Lasheras A et al. A prospective study of the incidence of complications associated with dermatological surgery. Br J Dermatol 2005; 153: 967–71.
- 7Eisenstein DH. Anticoagulation management in the ambulatory surgical setting. AORN J 2012; 95: 510–21.
- 8Mayer K, Bernlochner I, Braun S et al. Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI Registry. J Am Coll Cardiol 2014; 64: 863–71.
